IEPF

 
Year Document   Report

June 2018 List of shareholders (Erstwhile Shasun Pharmaceuticals) - for FY 2011 PDF 96 KB
March 2018 List of shareholders - relating to FY ending December 2010 PDF 92 KB
October 2017 List of Shareholders – transfer of shares to IEPF Account PDF 321 KB
Consolidated Unclaimed/ Unpaid Dividend Data

The Consolidated unclaimed/ unpaid dividend details as required by the Investor Education and Protection Fund (Uploading of information regarding unpaid and unclaimed amounts lying with companies) Rules, 2012, are provided herein below for all the unclaimed/unpaid dividend accounts outstanding for the respective financial years.


FY 2016 - 2017

FY 2015 - 2016

FY 2014 - 2015

FY 2013 - 2014
 
Unclaimed Shares Suspense Account

Pursuant to Regulation 39(4) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 read with Schedule VI of the said Regulations, the Company has dematerialized shares which have been returned undelivered by postal authorities and shares lying unclaimed. The dematerialized shares are held in an ‘unclaimed suspense account’ opened with Karvy Stock Broking Limited.

Any corporate benefits accruing on such shares, viz. bonus shares, split etc., shall also be credited to unclaimed suspense account, for a period of seven years and thereafter shall be transferred by the Company to IEPF, in accordance with provisions of Section 124(5) and (6) of the Companies Act, 2013 and rules made thereunder.

In accordance with the provisions of the Listing Regulations, the Company reports the following details in respect of equity shares lying in the suspense account.

Particulars Number of shareholders Number of equity shares
Aggregate number of shareholders and the outstanding shares in the suspense account lying at the beginning of the year 2,552 1,01,636
Shareholders who approached the Company for transfer of shares from suspense account during the year 17 1,580
Shareholders to whom shares were transferred from the suspense account during the year 17 1,580
Aggregate number of shareholders and shares which were transferred to IEPF as per the MCA Circular 1,342 28,831
Aggregate number of shareholders and the outstanding shares in the suspense account lying as on March 31, 2018 1,193 71,225

The voting rights on the shares outstanding in the suspense account as on March 31, 2018 shall remain frozen till the rightful owner of such shares claims the shares.

Unpaid/ Unclaimed Dividends and Shares

In accordance with the provisions of Sections 124 and 125 of Companies Act, 2013 and Investor Education and Protection Fund (Accounting, Audit, Transfer and Refund) Rules, 2016 (IEPF Rules) dividends not encashed/ claimed within seven years from the date of declaration are to be transferred to the Investor Education and Protection Fund (IEPF) Authority.

The IEPF Rules mandate companies to transfer shares of Members whose dividends remain unpaid/ unclaimed for a continuous period of seven years to the demat account of IEPF Authority. The Members whose dividend/ shares are transferred to the IEPF Authority can claim their shares/ dividend from the Authority.

In accordance with the said IEPF Rules and its amendments, the Company had sent notices to all the Shareholders whose shares were due to be transferred to the IEPF Authority and simultaneously published newspaper advertisement.

In terms of the provisions of Investor Education and Protection Fund (Accounting, Audit, Transfer and Refund) Rules, 2016/ Investor Education and Protection Fund (Awareness and Protection of Investors) Rules, 2001, Rs. 680,613/- of unpaid/ unclaimed dividends and 53,642 shares were transferred during the financial year 2017-18 to the Investor Education and Protection Fund.

The Company has appointed a Nodal Officer under the provisions of IEPF, the details of which are available on the website of the Company.

The Company has uploaded the details of unpaid and unclaimed amounts lying with the Company as on September 15, 2017 (date of last AGM) on the Company’s website.

Due date for transfer of unpaid/ unclaimed dividend to IEPF is as follows:

Financial Year Ending Type of Dividend Dividend
Rate
Date of declaration Due date for transfer to IEPF
31 Dec
2010
Final 15% 30 May 2011 05 Jul 2018
31 Dec
2011
Final 20% 25 May 2012 30 Jun 2019
31 Dec
2012
Final 20% 10 Jun 2013 16 Jul 2020
31 Mar
2014
Special 5000% 10 Dec 2013 15 Jan 2021
Final 50% 9 Sepr 2014 15 Oct 2021
31 Mar
2015
Special 1050% 7 Oct 2014 12 Nov 2021
Final 30% 30 Jul 2015 04 Sep 2022
31 Mar
2016
Final 40% 29 Jul 2016 03 Sep 2023
31 Mar
2017
Final 45% 15 Sep 2017 21 Oct 2024
Outstanding Amount from sale of Fractional Shares*
27 Jan
2016
NA NA NA 03 Mar 2023
Outstanding Dividend Amount pertaining to Unclaimed Shares in Suspense Account
17 Aug
2016
NA NA NA 22 Sep 2023

* Arising on account of sale of fractional shares pursuant to merger of Shasun with Strides.

Due dates for transfer of unpaid/ unclaimed dividends to IEPF of erstwhile Shasun Pharmaceuticals Limited is as follows:

Financial Year Ending Type of Dividend Dividend Rate Date of declaration Due date for transfer to IEPF
31 Mar
2011
Final 15% 29 Jul 2011 03 Sep 2018
31 Mar
2012
Interim 100% 15 Mar 2012 20 Apr 2019
Final 20% 02 Aug 2012 07 Sep 2019
31 Mar
2013
Final 75% 02 Aug 2013 07 Sep 2020
31 Mar
2014
Final 50% 06 Aug 2014 11 Sep 2021
31 Mar
2016
Interim 50% 30 July 2015 04 Sep 2022

The Members of the Company, who have not yet encashed their divided warrant (s), may write to the Company/ Registrar and Share Transfer Agents immediately.

Dematerialization of Shares & Liquidity

The Company shares are compulsorily traded in dematerialized form. The Company has established connectivity with both the Depositories viz., National Securities Depository Limited (NSDL) and Central Depository Services (India) Limited (CDSL) through the Registrar, Karvy Computershare Private Limited.

As at 31st March 2018, 99.80% of the paid-up share capital of the Company representing 89,319,533 shares has been dematerialized and balance 0.20% representing 180,502 shares of the Company is in physical form.

Updation of PAN and Bank Details of Shareholders

Pursuant to SEBI circular bearing reference SEBI/HO/MIRSD/DOP1/CIR/P/2018/73 dated April 20, 2018, the Company through its Registrar and Transfer Agents has initiated collection of copies of PAN and bank account details of the shareholders holding shares in physical form.   

In this connection, Company has sent reminders to shareholders holding shares in physical form, requesting them to register/ update their PAN and bank account details. For ease of shareholders and effective updation, Company has provided postage paid/ pre-paid Business Reply Envelopes (BRE).

SEBI restriction on transfer of physical shares

SEBI vide its Notification no. SEBI/ LAD-NRO/GN/2018/24 has notified that with effect from December 5, 2018, except in case of transmission or transposition of securities, requests for effecting the transfer of securities shall not be processed unless the securities are held in the dematerialized form with a depository. Listing Regulations are appropriately amended to this effect.

In other words, there will not be any transfer of physical shares after 5 Dec 2018.

The said measure of SEBI is aimed at curbing fraud and manipulation risk in physical transfer of securities by unscrupulous entities. Transfer of securities only in demat form will improve ease, convenience and safety of transactions for investors.

Shareholders who continue to hold shares in physical form are advised to dematerialize their shares at the earliest. For any clarification, assistance or information relating to dematerialization of shares – members may contact the Company’s RTA.

Nodal Officer for IEPF

Ms. Manjula Ramamurthy
Company Secretary
Strides Pharma Science Limited
(Formerly Strides Shasun Limited)
Bangalore – 560 076
Ph: +91 80 6784 0734
Mob: +91 9880667807
Email:
Manjula.r@strides.com
investors@strides.com